Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Steven Burke

The proxy statement of Akebia Therapeutics, Inc. reports total compensation of $1,859,815 for Steven Burke in fiscal 2025, including a base salary of $600,538. Disclosed compensation is on record for 5 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Akebia Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Akebia Therapeutics, Inc. (AKBA) $600,538 $1,859,815
2024 Akebia Therapeutics, Inc. (AKBA) $579,653 $1,811,027
2023 Akebia Therapeutics, Inc. (AKBA) $553,104 $1,213,048
2022 Akebia Therapeutics, Inc. (AKBA) $526,766 $1,378,558
2021 Akebia Therapeutics, Inc. (AKBA) $494,623 $1,346,572

Recent activity

No call appearances or filed executive changes recorded yet.